Skip to main content
OpenTrials

Clinical trial condition

Metastatic Castration-resistant Prostate Neoplasms

Explore clinical trials studying Metastatic Castration-resistant Prostate Neoplasms. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Castration-resistant Prostate Neoplasms trial results

Recruiting

A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

NCT05818683

Conditions
Metastatic Castration-resistant Prostate Neoplasms, Metastatic Hormone-sensitive Prostate Cancer
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Start Midwest Grand Rapids, Michigan, United States
  • Washington University School Of Medicine St Louis, Missouri, United States
  • Perlmutter Cancer Center at NYU Langone Brooklyn Brooklyn, New York, United States
View all 15 locations
View Trial Details
Recruiting

A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT07164443

Conditions
Metastatic Castration-resistant Prostate Neoplasms
Locations
  • University of California at San Diego La Jolla, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
View all 172 locations
View Trial Details

Related conditions